NMRD logo

Nemaura Medical Inc. Stock Price

OTCPK:NMRD Community·US$8.1k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NMRD Share Price Performance

US$0.0002
0.00 (0.00%)
US$0.0002
0.00 (0.00%)
Price US$0.0002

NMRD Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Nemaura Medical Inc. Key Details

US$0

Revenue

US$1.5m

Cost of Revenue

-US$1.5m

Gross Profit

US$9.2m

Other Expenses

-US$10.7m

Earnings

Last Reported Earnings
Dec 31, 2023
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About NMRD

Founded
2009
Employees
n/a
CEO
Dewan Fazlul Chowdhury
WebsiteView website
nemauramedical.com

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Recent NMRD News & Updates

Recent updates

No updates